Procalcitonin as a Biomarker in Respiratory Tract Infection

被引：107
|
作者：
Gilbert, David N. [1 ,2 ]
机构：
[1] Providence Portland Med Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷
关键词：
COMMUNITY-ACQUIRED PNEUMONIA; CALCITONIN-I GENE; ANTIBIOTIC-TREATMENT; SERUM PROCALCITONIN; INFLAMMATION; EXPRESSION; PATHOGENS; DIAGNOSIS; BACTERIAL; GUIDANCE;
D O I：
10.1093/cid/cir050
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Serum procalcitonin (PCT) levels rapidly increase in patients with invasive bacterial disease. PCT levels increase faster than do C-reactive protein levels. Furthermore, a rapid decrease in the PCT level is supporting evidence that the source of the bacterial infection is responding to clinical management. In patients with community-acquired bacterial pneumonia, sequential PCT levels are useful as a guide to shorter courses of antimicrobial therapy. With use of emerging multiplex real-time polymerase chain reaction platforms for the detection of viral and bacterial respiratory pathogens, it should be possible to critically assess whether an elevated serum PCT level is a valid biomarker of invasive bacterial infection.
引用
收藏
页码：S346 / S350
页数：5
相关论文
共 50 条
  • [21] A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection
    Husain, Shahid
    Sage, Andrew T.
    del Sorbo, Lorenzo
    Cypel, Marcelo
    Martinu, Tereza
    Juvet, Stephen C.
    Mariscal, Andrea
    Wright, Julie
    Chao, Bonnie T.
    Shamandy, Alaa A.
    Mousavi, S. Hossein
    Ma, Jin
    Wang, Bo
    Valero, Jerome
    Liu, Mingyao
    Landes, Megan
    Balachandran, Sharaniyaa
    Hudson, Kimberley
    Ngai, Michelle
    Capuano, Marialessia
    Gelardi, Maria
    Lupia, Enrico
    Marinowic, Daniel R.
    Friedrich, Frederico O.
    Schmitz, Carine R. R.
    dos Santos, Leticya S. M.
    Barbe-Tuana, Florencia M.
    Jones, Marcus H.
    Kain, Kevin C.
    Mazzulli, Tony
    Sabbah, Sam
    Keshavjee, Shaf
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (06)
  • [22] Salivary IgA as a Potential Biomarker in the Evaluation of Respiratory Tract Infection Risk in Athletes
    Turner, Scarlett E. G.
    Loosemore, Mike
    Shah, Anand
    Kelleher, Peter
    Hull, James H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (01): : 151 - 159
  • [23] Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
    David T. Huang
    Derek C. Angus
    Chung-Chou H. Chang
    Yohei Doi
    Michael J. Fine
    John A. Kellum
    Octavia M. Peck-Palmer
    Francis Pike
    Lisa A. Weissfeld
    Jonathan Yabes
    Donald M. Yealy
    BMC Emergency Medicine, 17
  • [24] Procalcitonin-guided treatment of respiratory tract infections
    Ebell, Mark
    AMERICAN FAMILY PHYSICIAN, 2008, 78 (06) : 756 - 757
  • [25] Design and rationale of the Procalcitonin Antibiotic Consensus Trial (ProACT), a multicenter randomized trial of procalcitonin antibiotic guidance in lower respiratory tract infection
    Huang, David T.
    Angus, Derek C.
    Chang, Chung-Chou H.
    Doi, Yohei
    Fine, Michael J.
    Kellum, John A.
    Peck-Palmer, Octavia M.
    Pike, Francis
    Weissfeld, Lisa A.
    Yabes, Jonathan
    Yealy, Donald M.
    BMC EMERGENCY MEDICINE, 2017, 17
  • [26] Respiratory tract infection
    Saito, A
    Kawakami, K
    Higa, F
    INTERNAL MEDICINE, 2001, 40 (02) : 171 - 172
  • [27] Procalcitonin guidance to reduce antibiotic treatment of children with lower respiratory tract infection-The Propaed Study
    Bonhoeffer, Jan
    Baumann, Philipp
    Baer, Gurli
    Heininger, Ulrich
    EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (02) : 262 - 262
  • [28] Serum Procalcitonin Level, Viral Polymerase Chain Reaction Analysis, and Lower Respiratory Tract Infection Reply
    Falsey, Ann R.
    Walsh, Edward E.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (04): : 633 - U157
  • [29] Procalcitonin-Guided Antibiotic Prescription for Suspected Lower Respiratory Tract Infection; A Randomized Clinical Trial
    Huang, D. T.
    Yealy, D. M.
    Filbin, M. R.
    Brown, A. M.
    Chang, C. H.
    Doi, Y.
    Donnino, M. W.
    Fine, J. M.
    Fine, M. J.
    Fischer, M. A.
    Holst, J. M.
    Hou, P. C.
    Kellum, J. A.
    Khan, F.
    Kurz, M. C.
    Lotfipour, S.
    LoVecchio, F.
    Peck-Palmer, O. M.
    Pike, F.
    Prunty, H.
    Sherwin, R. L.
    Southerland, L.
    Terndrup, T.
    Weissfeld, L. A.
    Yabes, J.
    Angus, D. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [30] Should procalcitonin be used as a routine biomarker of bacterial infection?
    R. R. Das
    Infection, 2012, 40 : 713 - 714
12345